Purchase Order 75N94021P00264
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The $4,250.00 contract does not have a set-aside designation. The contract provides for the delivery and installation of Miltenyi...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $5,291.00, is for the delivery of GENTLE MACS instruments, which are specialized tissue dissociation devices. The contract is not set aside and represents one of numerous awards Miltenyi Biotec has received from various government...
- This is a $14,647 firm fixed-price purchase order awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID) for the delivery of a GentleMACS tissue homogenizer and associated supplies. The award is not associated with a set-aside. Miltenyi Biotec is an experienced federal contractor, having received numerous awards from agencies such as the NIH, VA, and DoD to provide specialized laboratory equipment, reagents, and...
- This is a $18,639.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is for the delivery of Miltenyi's tissue dissociator and associated laboratory equipment. This award is part of a larger indefinite delivery contract (IDC) worth $2.3 million that Miltenyi Biotec holds with the NIH Clinical...
- This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $4,881.00 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a global biotechnology company, for a GENTLEMACS DISSOCIATOR. This contract is not set-aside and has an ultimate completion date of September 16, 2015. Miltenyi Biotec is a prime contractor with significant experience supplying specialized laboratory instruments, reagents, and services to...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Miltenyi Biotec, Inc., a global biotechnology company. The $6,966.00 contract is for the provision of GentleMACS starting kits, which are specialized tissue dissociation instruments and reagents used in biomedical research and cell therapy development. The award is not associated with a larger contract vehicle and does not have a set-aside...
- This is a $5,143.50 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. for a GENTLEMACS DISSOCIATOR. The contract has no set-aside designation and was awarded on March 23, 2016 with a completion date of April 5, 2016. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support...
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The $5,406.00 firm fixed-price purchase order is for the delivery of a GentleMACS Dissociator instrument, a specialized tissue dissociation system used in biomedical research. The contract is not designated as a set-aside. Miltenyi Biotec is a global biotechnology company that provides scientific instruments,...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc. in the amount of $24,646.00. The contract is for the delivery of Miltenyi's GentleMACS instruments and associated products, which are used for cell separation, analysis, and processing in biomedical research. Miltenyi Biotec is a global biotechnology company that provides specialized scientific equipment, reagents, and services to government agencies, including the NIH, VA, FDA, DoD, CDC, and USDA. This contract is not set aside, and the company has extensive experience as a prime contractor for federal customers. The award appears to be part of a larger indefinite delivery contract (IDC) with the NIH Clinical Center valued at $2.3 million, which ensures the availability of Miltenyi's FDA-approved, clinical-grade reagents and supplies to support the NIH's cell therapy manufacturing and research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.6k | 3/17/21 |